News + Filings Transactions Holdings
|
AISLING CAPITAL III LP
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/10/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 1.4M | $179.43 | $251.2M | | 07/10/2018 |
| 12/19/2017 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 250k | $80.50 | $20.1M | | 12/19/2017 |
| 11/22/2017 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 500k | $75.00 | $37.5M | | 11/22/2017 |
| 12/11/2015 | Loxo Oncology, Inc. | LOXO | Purchase | Common Stock | 200 | $27.50 | $5.5k | | 12/11/2015 |
| 12/09/2015 | T2 Biosystems, Inc. | TTOO | Purchase | Common Stock | 307.7k | $9.75 | $3M | See footnote | 12/09/2015 |
| 11/17/2015 | Loxo Oncology, Inc. | LOXO | Purchase | Common Stock | 265k | $26.50 | $7M | | 11/17/2015 |
| 11/13/2015 | Loxo Oncology, Inc. | LOXO | Purchase | Common Stock | 2k | $27.47 | $53.7k | | 11/12/2015 |
| 11/12/2015 | Loxo Oncology, Inc. | LOXO | Purchase | Common Stock | 76.7k | $27.65 | $2.1M | | 11/12/2015 |
| 01/27/2015 | Aravive, Inc. | ARAV | Purchase | Common Stock | 145k | $17.25 | $2.5M | See FN | 01/27/2015 |
| 08/12/2014 | T2 Biosystems, Inc. | TTOO | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnote | 08/12/2014 |
| 08/12/2014 | T2 Biosystems, Inc. | TTOO | Purchase | Common Stock | 454.5k | $11.00 | $5M | See footnote | 08/12/2014 |
| 08/12/2014 | T2 Biosystems, Inc. | TTOO | Conversion | Series D Convertible Preferred Stock | 3M | $0.00 | $0 | See footnote | 08/12/2014 |
| 08/12/2014 | T2 Biosystems, Inc. | TTOO | Conversion | Series E Convertible Preferred Stock | 549.9k | $0.00 | $0 | See footnote | 08/12/2014 |
| 08/06/2014 | Loxo Oncology, Inc. | LOXO | Purchase | Common Stock | 413.1k | $13.00 | $5.4M | | 08/06/2014 |
| 08/06/2014 | Loxo Oncology, Inc. | LOXO | Conversion | Series A Convertible Preferred Stock | 2.3M | $0.00 | $0 | | 08/06/2014 |
| 08/06/2014 | Loxo Oncology, Inc. | LOXO | Conversion | Series B Convertible Preferred Stock | 507k | $0.00 | $0 | | 08/06/2014 |
| 08/06/2014 | Loxo Oncology, Inc. | LOXO | Conversion | Common Stock | 2.9M | $0.00 | $0 | | 08/06/2014 |
| 05/20/2014 | Durata Therapeutics, Inc. | DRTX | Other (disposition) | Common Stock | 745.7k | $0.00 | $0 | | 05/20/2014 |
| 05/20/2014 | Durata Therapeutics, Inc. | DRTX | Other (disposition) | Common Stock | 3.5k | $0.00 | $0 | | 05/20/2014 |
| 04/21/2014 | ASENSUS SURGICAL, INC. | TRXC | Purchase | Common Stock | 1M | $4.00 | $4.2M | By Aisling Capital III, LP | 04/21/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Common Stock | 35.1k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Common Stock | 1.2M | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Common Stock | 128.7k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Common Stock | 56.9k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Common Stock | 477.1k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Purchase | Common Stock | 60k | $21.00 | $1.3M | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Series B Convertible Preferred Stock | 403.7k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Series C Convertible Preferred Stock | 14.2M | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Series D-1 Convertible Preferred Stock | 1.5M | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Series D-2 Convertible Preferred Stock | 654.8k | $0.00 | $0 | See FN | 03/26/2014 |
| 03/26/2014 | Aravive, Inc. | ARAV | Conversion | Series E Convertible Preferred Stock | 5.5M | $0.00 | $0 | See FN | 03/26/2014 |
| 03/21/2014 | Durata Therapeutics, Inc. | DRTX | Sale | Common Stock | 2.6k | $15.57 | $41.3k | By Aisling Capital III, LP | 03/20/2014 |
| 03/20/2014 | Durata Therapeutics, Inc. | DRTX | Sale | Common Stock | 98k | $15.74 | $1.5M | By Aisling Capital III, LP | 03/20/2014 |
| 12/06/2013 | ASENSUS SURGICAL, INC. | TRXC | Conversion | Common Stock | 12.4M | $0.00 | $0 | By Aisling Capital III, LP | 12/06/2013 |
| 07/24/2012 | ASENSUS SURGICAL, INC. | TRXC | Conversion | Series B Preferred Stock | 1.2M | $0.00 | $0 | By Aisling Capital III, LP | 12/06/2013 |
|